160 related articles for article (PubMed ID: 8431019)
1. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.
Toyosawa T; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
Antimicrob Agents Chemother; 1993 Jan; 37(1):60-6. PubMed ID: 8431019
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
Hata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.
Watanabe N; Hiruma R; Katsu K
Antimicrob Agents Chemother; 1992 Mar; 36(3):589-97. PubMed ID: 1622167
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
Mitsukude M; Inoue M; Mitsuhashi S
Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
Fu KP; Foleno BD; Lafredo SC; LoCoco JM; Isaacson DM
Antimicrob Agents Chemother; 1993 Feb; 37(2):301-7. PubMed ID: 8452361
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.
Iwahi T; Okonogi K; Yamazaki T; Shiki S; Kondo M; Miyake A; Imada A
Antimicrob Agents Chemother; 1992 Jul; 36(7):1358-66. PubMed ID: 1510428
[TBL] [Abstract][Full Text] [Related]
9. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
[TBL] [Abstract][Full Text] [Related]
10. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
Asahi Y; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin.
Tsuji M; Ishii Y; Ohno A; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1995 Nov; 39(11):2544-51. PubMed ID: 8585742
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
17. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
